Trial Profile
Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Multiple Sclerosis (MIRROR)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Oct 2023
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms MIRROR
- 05 Nov 2019 Status changed from active, no longer recruiting to completed.
- 16 Apr 2019 Planned End Date changed from 1 Apr 2019 to 1 Jul 2019.
- 16 Apr 2019 Status changed from recruiting to active, no longer recruiting.